Health
Unique infectious profile makes Covid-19 hard to treat: Lancet – Business Standard
A review published in the prestigious journal The Lancet has revealed that the increase in caseloads is owing to a unique infectious profile
As the Covid-19 cases surge globally, especially in India, leaving many of us wonder why it is so hard to treat, a review published in the prestigious journal The Lancet has revealed that the increase in caseloads is owing to a unique infectious profile.
According to the review, there is growing evidence that the virus infects both the upper and lower respiratory tracts.
The review suggests that it is unlike “low pathogenic” human coronavirus sub-species, which typically settle in the upper respiratory…
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News11 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?